Olga A. Vorobeva

Olga A. Vorobeva

Auto-generated profile, based on publicly available information

Olga A. Vorobeva

Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Problems of Nutrition
Verified
Journal Article
Open access
OVO.A. Vorobieva
O.A. Vorobieva
ESEvgenia Shikh
Evgenia Shikh
VDV.N. Drozdov
V.N. Drozdov
NSN.V. Shikh
N.V. Shikh
Результаты применения комбинированного пробиотика (Lactobacillus rhamnosus GG и Bifidobacterium animalis spp. lactis ВB-12) у детей с

1 January 2022 in Problems of Nutrition
Verified
Journal Article
Closed access
ESEvgenia Shikh
Evgenia Shikh
VDV.N. Drozdov
V.N. Drozdov
OVO.A. Vorobieva
O.A. Vorobieva
OZO.V. Zhukova
O.V. Zhukova
AEA.S. Ermolaeva
A.S. Ermolaeva
ABAlina Bagdasaryan
Alina Bagdasaryan
Возможности применения пробиотика БИФИФОРМ КИДС с целью профилактики заболеваемости острыми респираторными вирусными инфекциями у детей

31 August 2022 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
ENE. Yu. Nikitin
E. Yu. Nikitin
VDV. N. Drozdov
V. N. Drozdov
MVM. A. Vyzhigina
M. A. Vyzhigina
OVO. A. Vorobieva
O. A. Vorobieva
AAA. A. Astapovskiy
A. A. Astapovskiy
ESEvgenia Shikh
Evgenia Shikh
The developers of Clinical Practice Guidelines for Acute Kidney Injury titled The Initiative to Improve Global Kidney Disease Outcomes (KDIGO) point at the need of new biomarkers for diagnosis acute kidney injury (AKI).The objective: to study and evaluate the diagnostic significance of the levels of neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) in patients with AKI in the early postoperative period when antibiotic therapy is used.Subjects and Methods. AKI frequency was assessed in 276 patients during the early postoperative period after the antibacterial drugs had been prescribed. Serum levels of KIM-1 and NGAL, glomerular filtration rate (GFR), creatinine, protein in urine were tested before the start of antibiotic therapy, in 24–48 hours, and in patients with AKI – additionally in 72–96 hours. The normal initial renal excretory function was registered only in 36 patients (13.04%). The majority of patients (242 patients, 86.96%) were diagnosed with chronic kidney disease of various stages.Results. NGAL and KIM-1 levels were higher in the group of patients with AKI before start of antibiotic therapy versus the group of patients with preserved renal function. However, a statistically significant increase in the level of KIM-1 and NGAL was found only in the group of patients with stages 3A and 3B of CKD versus the groups of patients with stages 1 and 2 of CKD. The second important observation is that a comorbid pathology in patients led to a high AKI incidence when antibiotic therapy was used – 35.86% (30–42%; 95%CI).Conclusion. The relationship of NGAL and KIM-1 levels with glomerular filtration rate (GFR) and KIM-1 level with the presence of proteinuria as indicators of impaired renal filtration function suggests that NGAL and KIM-1 levels reflect the state of renal filtration function. Based on this observation, it should be accepted that NGAL and KIM-1 levels can be used as markers for the diagnosis of AKI in patients receiving antibiotic therapy. The prescription of antibiotic therapy in the postoperative period in patients with surgical pathology and renal dysfunction leads to a high AKI incidence. Elevated KIM-1 and NGAL levels in AKI during the antibiotic therapy suggests their involvement in the reparation process.

24 November 2019 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
VDV. N. Drozdov
V. N. Drozdov
OVO. A. Vorob’eVa
O. A. Vorob’eVa
SSS. Yu. Serebrova
S. Yu. Serebrova
ESE. V. Shikh
E. V. Shikh
The follow-up group of «frequently ill children» is formed on the basis of criteria formulated by domestic pediatricians A.A. Baranov and V.Yu. Al’bitskiy, due to the high relevance of medical, social and economic problems caused by the increased morbidity in this category of patients especially with acute respiratory infections, with likely development of severe complications or the manifestation of chronic respiratory diseases. In general, the state of the immune system in frequently ill children is characterized by decreased local immunity and increased stress of systemic immunity, and the features of the functional immunity activity in this category of patients determine the various possibilities to affect immunity during the prevention and treatment of acute respiratory infections. This article discusses the features of the functional activity of the immune system in frequently ill children, as well as the possibilities of drug management of its disorders and the benefits of using inosine pranobex to prevent and treat respiratory infections in this category of patients. According to the international classification of drugs maintained by the World Health Organization, the drug belongs to the groups of immunomodulators (L) and antimicrobial antiviral drugs (J) for systemic use. It is proved that inosine pranobex effectively increases cellular and humoral immunity, and reduces non-specifically the viral replication capacity. During clinical trials, the drug proved to be a highly effective and safe component of the complex treatment of acute respiratory infections in frequently ill children. The use of inosine pranobex reduces the duration and intensity of symptoms of infectious respiratory tract diseases. The drug can be recommended for children with concomitant chronic respiratory tract diseases.

26 November 2019 in Current Pediatrics
Verified
Journal Article
Open access
PDF file
VDVladimir N. Drozdov
Vladimir N. Drozdov
OVOlga A. Vorob'EVa
Olga A. Vorob'EVa
AAAleksandr A. Astapovsky
Aleksandr A. Astapovsky
ESEvgenia Shikh
Evgenia Shikh
ОВО. А. Воробьёва
О. А. Воробьёва
Пробиотики в педиатрии: как подойти к выбору эффективного и безопасного препарата для детей

4 April 2025 in Pediatrics. Consilium Medicum
Verified
Journal Article
Open access
PDF file
OVOlga A. Vorobeva
Olga A. Vorobeva
VDVladimir N. Drozdov
Vladimir N. Drozdov
AKAlina S. Kiose
Alina S. Kiose
RKRuslan E. Kazakov
Ruslan E. Kazakov
ESEvgenia Shikh
Evgenia Shikh
ШВШих Евгения Валерьевна
Ших Евгения Валерьевна
Background. Respiratory infections are very common in children. Currently, various studies are being conducted to determine additional markers of high incidence of respiratory infections in children. Polymorphisms of the vitamin D receptor gene (VDR) are associated with the risk of developing various diseases, including infectious diseases. Aim. To assess the relationship between VDR gene polymorphisms and the incidence of respiratory infections in infants. Materials and methods. During the study, we assessed the number of respiratory infection episodes in the first 6 months of a child’s life, determined the FokI (rs2228570) and TaqI (rs731236) polymorphisms of the vitamin D receptor gene. Results. The results of the study showed that the presence of minor TT alleles of the FokI gene is associated with a higher frequency of respiratory infections in children in the first 6 months of life. The risk of developing 4 or more episodes of respiratory infections in the first 6 months of life was 4.8 times higher in children who had this genotype (95% CI 2.19–10.5). Conclusion. The presence of minor TT alleles of the FokI gene is associated with a high frequency (more than 4 episodes) of respiratory infections in children in the first 6 months of life.